{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:39:01Z","timestamp":1787776741438,"version":"build-2784847793"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":1366,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT109965MA"],"award-info":[{"award-number":["WT109965MA"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human type 2 cytotoxic T (Tc2) cells are enriched in severe eosinophilic asthma and can contribute to airway eosinophilia. PGD2 and its receptor PGD2 receptor 2 (DP2) play important roles in Tc2 cell activation, including migration, cytokine production, and survival. In this study, we revealed novel, to our knowledge, functions of the PGD2\/DP2 axis in Tc2 cells to induce tissue-remodeling effects and IgE-independent PGD2 autocrine production. PGD2 upregulated the expression of tissue-remodeling genes in Tc2 cells that enhanced the fibroblast proliferation and protein production required for tissue repair and myofibroblast differentiation. PGD2 stimulated Tc2 cells to produce PGD2 using the routine PGD2 synthesis pathway, which also contributed to TCR-dependent PGD2 production in Tc2 cells. Using fevipiprant, a specific DP2 antagonist, we demonstrated that competitive inhibition of DP2 not only completely blocked the cell migration, adhesion, proinflammatory cytokine production, and survival of Tc2 cells triggered by PGD2 but also attenuated the tissue-remodeling effects and autocrine\/paracrine PGD2 production in Tc2 induced by PGD2 and other stimulators. These findings further confirmed the anti-inflammatory effect of fevipiprant and provided a better understanding of the role of Tc2 cells in the pathogenesis of asthma.<\/jats:p>","DOI":"10.4049\/jimmunol.2001245","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T15:05:20Z","timestamp":1621436720000},"page":"2714-2724","source":"Crossref","is-referenced-by-count":20,"title":["The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D2 Production Are Attenuated by PGD2 Receptor 2 Antagonism"],"prefix":"10.1093","volume":"206","author":[{"given":"Wentao","family":"Chen","sequence":"first","affiliation":[{"name":"Respiratory Medicine Unit and National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Luo","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit and National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6541-0332","authenticated-orcid":false,"given":"Yuan","family":"Ye","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit and National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9084-962X","authenticated-orcid":false,"given":"Ryan","family":"Hoyle","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit and National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1811-9520","authenticated-orcid":false,"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit and National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2165-9894","authenticated-orcid":false,"given":"Rowie","family":"Borst","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit and National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1234-8253","authenticated-orcid":false,"given":"Shamsah","family":"Kazani","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research , Cambridge MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A","family":"Shikatani","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research , Cambridge MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit J","family":"Erpenbeck","sequence":"additional","affiliation":[{"name":"Novartis Pharma , AG, Basel ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4288-5973","authenticated-orcid":false,"given":"Ian D","family":"Pavord","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit and National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Klenerman","sequence":"additional","affiliation":[{"name":"Translational Gastroenterology Unit and Peter Medawar Building for Pathogen Research, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Sandham","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research , Cambridge MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0042-1262","authenticated-orcid":false,"given":"Luzheng","family":"Xue","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit and National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford , Oxford ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"2025030417503657800_r1","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1258\/0007142001903625","article-title":"Th-2 cytokines in allergic disease","volume":"56","author":"Robinson","year":"2000","journal-title":"Br. Med. Bull."},{"key":"2025030417503657800_r2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mj\u00f6sberg","year":"2011","journal-title":"Nat. Immunol."},{"key":"2025030417503657800_r3","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41385-018-0049-9","article-title":"Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma.[Published erratum appears in 2019 Mucosal Immunol. 12: 581]","volume":"11","author":"Hilvering","year":"2018","journal-title":"Mucosal Immunol."},{"key":"2025030417503657800_r4","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#","article-title":"CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease","volume":"30","author":"Cosmi","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"2025030417503657800_r5","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4049\/jimmunol.129.4.1627","article-title":"Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE","volume":"129","author":"Lewis","year":"1982","journal-title":"J. Immunol."},{"key":"2025030417503657800_r6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1183\/09031936.93.06030405","article-title":"Increased LTB4 metabolites and PGD2 in BAL fluid after methacholine challenge in asthmatic subjects","volume":"6","author":"Nowak","year":"1993","journal-title":"Eur. Respir. J."},{"key":"2025030417503657800_r7","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.jaci.2013.01.035","article-title":"Prostaglandin D2 pathway upregulation: relation to asthma severity, control, and TH2 inflammation","volume":"131","author":"Fajt","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025030417503657800_r8","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.4049\/jimmunol.164.5.2277","article-title":"Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets","volume":"164","author":"Tanaka","year":"2000","journal-title":"J. Immunol."},{"key":"2025030417503657800_r9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1067\/mai.2001.119919","article-title":"Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP","volume":"108","author":"Gervais","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025030417503657800_r10","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.4049\/jimmunol.175.10.6531","article-title":"Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells","volume":"175","author":"Xue","year":"2005","journal-title":"J. Immunol."},{"key":"2025030417503657800_r11","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.4049\/jimmunol.0804090","article-title":"Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway","volume":"182","author":"Xue","year":"2009","journal-title":"J. Immunol."},{"key":"2025030417503657800_r12","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","article-title":"Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells","volume":"133","author":"Xue","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025030417503657800_r13","first-page":"165","article-title":"CRTH2 antagonists in asthma: current perspectives","volume":"9","author":"Singh","year":"2017","journal-title":"Clin. Pharmacol."},{"key":"2025030417503657800_r14","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jaip.2019.11.016","article-title":"A phase 2a study of DP2 antagonist GB001 for asthma","volume":"8","author":"Asano","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"2025030417503657800_r15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pupt.2016.06.005","article-title":"The oral CRTh2 antagonist QAW039 (fevipiprant): a phase II study in uncontrolled allergic asthma","volume":"39","author":"Erpenbeck","year":"2016","journal-title":"Pulm. Pharmacol. Ther."},{"key":"2025030417503657800_r16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(16)30179-5","article-title":"Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial","volume":"4","author":"Gonem","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"2025030417503657800_r17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1021\/acsmedchemlett.7b00157","article-title":"Discovery of fevipiprant (NVP-QAW039), a potent and selective DP2 receptor antagonist for treatment of asthma","volume":"8","author":"Sandham","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"2025030417503657800_r18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S2213-2600(20)30412-4","article-title":"Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials","volume":"9","author":"Brightling","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"2025030417503657800_r19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molcel.2018.08.009","article-title":"Structures of the human PGD2 receptor CRTH2 reveal novel mechanisms for ligand recognition","volume":"72","author":"Wang","year":"2018","journal-title":"Mol. Cell"},{"key":"2025030417503657800_r20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/mol.115.101832","article-title":"Fevipiprant (QAW039), a slowly dissociating CRTh2 antagonist with the potential for improved clinical efficacy","volume":"89","author":"Sykes","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"2025030417503657800_r21","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jaci.2019.02.015","article-title":"Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function","volume":"143","author":"Hardman","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025030417503657800_r22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. [Published erratum appears in 2014 Eur. Respir. J. 43: 1216.]","volume":"43","author":"Chung","year":"2014","journal-title":"Eur. Respir. J."},{"key":"2025030417503657800_r23","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"2025030417503657800_r24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.pharmthera.2006.05.001","article-title":"Airway remodelling in asthma: current understanding and implications for future therapies","volume":"112","author":"Tang","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"2025030417503657800_r25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3390\/ijms21030757","article-title":"Immunologic and non-immunologic mechanisms leading to airway remodeling in asthma","volume":"21","author":"Fang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"2025030417503657800_r26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0021-9150(93)90052-V","article-title":"Effect of interleukin-1 receptor antagonist on vascular smooth muscle cell proliferation","volume":"99","author":"Porreca","year":"1993","journal-title":"Atherosclerosis"},{"key":"2025030417503657800_r27","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1161\/01.CIR.0000014987.32865.8E","article-title":"Direct evidence for tumor necrosis factor-\u03b1 signaling in arteriogenesis","volume":"105","author":"Hoefer","year":"2002","journal-title":"Circulation"},{"key":"2025030417503657800_r28","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1073\/pnas.1117885109","article-title":"Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle","volume":"109","author":"Jang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030417503657800_r29","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1582-4934.2011.01356.x","article-title":"Brain-derived neurotrophic factor induces proliferation of human airway smooth muscle cells","volume":"16","author":"Aravamudan","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"2025030417503657800_r30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/jid.2014.288","article-title":"Galectin-1 accelerates wound healing by regulating the neuropilin-1\/Smad3\/NOX4 pathway and ROS production in myofibroblasts","volume":"135","author":"Lin","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"2025030417503657800_r31","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1002\/jcb.26525","article-title":"TWEAK\/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-\u03baB pathway","volume":"119","author":"Zhu","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"2025030417503657800_r32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/1043-4666(93)90024-Y","article-title":"Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica","volume":"5","author":"Piguet","year":"1993","journal-title":"Cytokine"},{"key":"2025030417503657800_r33","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/art.23645","article-title":"The controversial role of tumor necrosis factor \u03b1 in fibrotic diseases","volume":"58","author":"Distler","year":"2008","journal-title":"Arthritis Rheum."},{"key":"2025030417503657800_r34","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1172\/JCI41203","article-title":"Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF\/TGF-\u03b2 signaling in hepatic stellate cells","volume":"120","author":"Cao","year":"2010","journal-title":"J. Clin. Invest."},{"key":"2025030417503657800_r35","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1042\/BST20140244","article-title":"Neuropilin regulation of angiogenesis","volume":"42","author":"Lampropoulou","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"2025030417503657800_r36","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/07853890.2011.614635","article-title":"Thrombospondin-4, tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14: novel extracellular matrix modulating factors in cardiac remodelling","volume":"44","author":"Mustonen","year":"2012","journal-title":"Ann. Med."},{"key":"2025030417503657800_r37","doi-asserted-by":"crossref","first-page":"37635","DOI":"10.1038\/srep37635","article-title":"Overexpression of serpinE2\/protease nexin-1 contribute to pathological cardiac fibrosis via increasing collagen deposition","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"2025030417503657800_r38","doi-asserted-by":"crossref","first-page":"111504","DOI":"10.1016\/j.yexcr.2019.111504","article-title":"p75 neurotrophin receptor regulates NGF-induced myofibroblast differentiation and collagen synthesis through MRTF-A","volume":"383","author":"Liu","year":"2019","journal-title":"Exp. Cell Res."},{"key":"2025030417503657800_r39","doi-asserted-by":"crossref","first-page":"eaat6280","DOI":"10.1126\/science.aat6280","article-title":"Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury","volume":"363","author":"Harrison","year":"2019","journal-title":"Science"},{"key":"2025030417503657800_r40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biochi.2018.05.005","article-title":"Type I collagen induces mesenchymal cell differentiation into myofibroblasts through YAP-induced TGF-\u03b21 activation","volume":"150","author":"Liu","year":"2018","journal-title":"Biochimie"},{"key":"2025030417503657800_r41","doi-asserted-by":"crossref","first-page":"e77166","DOI":"10.1371\/journal.pone.0077166","article-title":"Smooth muscle \u03b1 actin (Acta2) and myofibroblast function during hepatic wound healing","volume":"8","author":"Rockey","year":"2013","journal-title":"PLoS One"},{"key":"2025030417503657800_r42","doi-asserted-by":"crossref","first-page":"E4320","DOI":"10.1073\/pnas.1519197113","article-title":"Vimentin coordinates fibroblast proliferation and keratinocyte differentiation in wound healing via TGF-\u03b2-Slug signaling","volume":"113","author":"Cheng","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030417503657800_r43","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cellsig.2004.02.007","article-title":"TGF-beta and TNF-alpha: antagonistic cytokines controlling type I collagen gene expression","volume":"16","author":"Verrecchia","year":"2004","journal-title":"Cell. Signal."},{"key":"2025030417503657800_r44","doi-asserted-by":"crossref","first-page":"L529","DOI":"10.1152\/ajplung.00387.2015","article-title":"Cooperative signaling by TGF-\u03b21 and WNT-11 drives sm-\u03b1-actin expression in smooth muscle via Rho kinase-actin-MRTF-A signaling","volume":"311","author":"Kumawat","year":"2016","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"2025030417503657800_r45","doi-asserted-by":"crossref","first-page":"eaao6451","DOI":"10.1126\/scitranslmed.aao6451","article-title":"DP2 antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment","volume":"11","author":"Saunders","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"2025030417503657800_r46","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jaci.2015.11.012","article-title":"Activated prostaglandin D2 receptors on macrophages enhance neutrophil recruitment into the lung","volume":"137","author":"Jandl","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025030417503657800_r47","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.4049\/jimmunol.1101806","article-title":"Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation","volume":"187","author":"Luna-Gomes","year":"2011","journal-title":"J. Immunol."},{"key":"2025030417503657800_r48","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.jaci.2018.10.069","article-title":"Cytokine-induced endogenous production of prostaglandin D2 is essential for human group 2 innate lymphoid cell activation","volume":"143","author":"Maric","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025030417503657800_r49","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/bph.14167","article-title":"Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system","volume":"176","author":"Mitchell","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"2025030417503657800_r50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0952-3278(03)00077-2","article-title":"Hematopoietic prostaglandin D synthase","volume":"69","author":"Kanaoka","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"2025030417503657800_r51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.rmed.2017.12.001","article-title":"A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels","volume":"134","author":"Haughney","year":"2018","journal-title":"Respir. Med."},{"key":"2025030417503657800_r52","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4049\/jimmunol.1102474","article-title":"Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2","volume":"188","author":"Xue","year":"2012","journal-title":"J. Immunol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/206\/11\/2714\/61368036\/ji2001245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/206\/11\/2714\/61368036\/ji2001245.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T12:58:36Z","timestamp":1741093116000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/206\/11\/2714\/7944651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.2001245","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6]]},"published":{"date-parts":[[2021,6,1]]}}}